Severity of Plasmodium vivax Malaria among Patients Presenting at Tertiary Care Hospital after Flood in Sindh – Pakistan
Severity of Plasmodium vivax Malaria
DOI:
https://doi.org/10.54393/pjhs.v4i10.1043Keywords:
Severe Malaria, Plasmodium vivax, ALOC, AnemiaAbstract
Malaria is one of the widely spread vector bond infectious disease responsible for grave health issues. Pakistan is one of the adversely hit country by malaria. We conducted this study to access whether there was only increase in no of malaria patients after flood in Sindh patients or clinical variance is also there. Objective: To assess the severity of Plasmodium vivax infection at a tertiary care hospital, after flood situation in Sindh. Methods: This cross-sectional study was conducted at LUMHS, Jamshoro from November 2022 to April 2023. After taking inform written consent, adult patients of age 13 to 60 years, irrespective of gender, with positive report of P. vivax malaria were included in the study. Data were recorded on predesigned proforma. Severity of malaria was determined according to the classification criteria. Data were analyzed with the help of SPSS version 23. Results: Out of total 170 patients, 52.4% female, mean age was 26.6 year. 50.6% patients of Plasmodium vivax found to suffer from severe malaria. Severe anemia, ALOC and jaundice were present in 28.2%, 21.2% and 11.2% of patients respectively. Conclusions: Enormous number of severe malaria cases due to of P. vivax was detected after floods in Sindh. Young age people were affected more, irrespective of gender. Severe anemia was the most common complication of malaria. Thrombocytopenia found frequently in patients infected with P. vivax.
References
Qureshi NA, Fatima H, Afzal M, Khattak AA, Nawaz MA. Occurrence and seasonal variation of human Plasmodium infection in Punjab Province, Pakistan. BMC Infectious Diseases. 2019 Dec; 19: 1-3. doi: 10.1186/s12879-019-4590-2. DOI: https://doi.org/10.1186/s12879-019-4590-2
World Health Organization. World Malaria Report 2022. 2022. [Last cited: 6th Oct 2023]. Available at: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022.
Directorate of Malaria Control Program. Malaria Annual Report 2018. [Last cited: 6th Oct 2023]. Available at: https://www.dmc.gov.pk/wp-content/uploads/2022/07/Annual-Report-2018.pdf.
World Health Organization. World malaria report 2018. 2018. [Last cited: 6th Oct 2023]. Available at: https://www.who.int/publications/i/item/9789241565653.
Tariq-Ali S, Zarina A, Shameel M. Seasonal variation and distribution of Euglenophycota in the Punjab. Pakistan Journal of Botany. 2010 Dec; 42(6): 4371-8.
Bibi Z, Fatima A, Rani R, Maqbool A, Khan S, Naz S, et al. Genetic characterization of Plasmodium vivax isolates from Pakistan using circumsporozoite protein (pvcsp) and merozoite surface protein-1 (pvmsp-1) genes as genetic markers. Malaria Journal. 2021 Dec; 20(1): 1-1. doi: 10.1186/s12936-021-03654-w. DOI: https://doi.org/10.1186/s12936-021-03654-w
Mathews SE, Bhagwati MM, Agnihotri V. Clinical spectrum of Plasmodium vivax infection, from benign to severe malaria: A tertiary care prospective study in adults from Delhi, India. Tropical Parasitology. 2019 Jul; 9(2): 88–92. doi: 10.4103/tp.TP_2_19. DOI: https://doi.org/10.4103/tp.TP_2_19
Khattak AA, Venkatesan M, Nadeem MF, Satti HS, Yaqoob A, Strauss K, et al. Prevalence and distribution of human Plasmodium infection in Pakistan. Malaria journal. 2013 Dec; 12(1): 1-8. doi: 10.1186/1475-2875-12-297. DOI: https://doi.org/10.1186/1475-2875-12-297
Ochani S, Aaqil SI, Nazir A, Athar FB, Ochani K, Ullah K. Various health-related challenges amidst recent floods in Pakistan; strategies for future prevention and control. Annals of Medicine and Surgery. 2022 Oct; 82: 104667. doi: 10.1016/j.amsu.2022.104667. DOI: https://doi.org/10.1016/j.amsu.2022.104667
Center for Disease Control and Prevention. Malaria. 2023. [Last cited: 6th Oct 2023]. Available at: https://www.cdc.gov/parasites/malaria/index.html.
Erdman LK and Kain KC. Molecular diagnostic and surveillance tools for global malaria control. Travel Medicine and Infectious Disease. 2008 Jan; 6(1-2): 82-99. doi: 10.1016/j.tmaid.2007.10.001. DOI: https://doi.org/10.1016/j.tmaid.2007.10.001
Foko LP, Arya A, Sharma A, Singh V. Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. Journal of Infection. 2021 Jun; 82(6): 231-46. doi: 10.1016/j.jinf.2021.03.028. DOI: https://doi.org/10.1016/j.jinf.2021.03.028
White NJ. Severe malaria. Malaria journal. 2022 Oct; 21(1): 284. doi: 10.1186/s12936-022-04301-8. DOI: https://doi.org/10.1186/s12936-022-04301-8
Yadav M, Dahiya N, Sehrawat N. Mosquito gene targeted RNAi studies for vector control. Functional & Integrative Genomics. 2023 Jun; 23(2): 180. doi: 10.1007/s10142-023-01072-6. DOI: https://doi.org/10.1007/s10142-023-01072-6
Zubairi AB, Nizami S, Raza A, Mehraj V, Rasheed AF, Ghanchi NK, et al. Severe Plasmodium vivax malaria in Pakistan. Emerging Infectious Diseases. 2013 Nov; 19(11): 1851. doi: 10.3201/eid1911.130495. DOI: https://doi.org/10.3201/eid1911.130495
Okiring J, Epstein A, Namuganga JF, Kamya EV, Nabende I, Nassali M, et al. Gender difference in the incidence of malaria diagnosed at public health facilities in Uganda. Malaria Journal. 2022 Dec; 21(1): 1-2. doi: 10.1186/s12936-022-04046-4. DOI: https://doi.org/10.1186/s12936-022-04046-4
Tovar-Acero C, Velasco MC, Avilés-Vergara PA, Ricardo-Caldera DM, Alvis EM, Ramirez-Montoya J, et al. Liver and kidney dysfunction, hypoglycemia, and thrombocytopenia in Plasmodium vivax malaria patients at a Colombian Northwest region. Parasite Epidemiology and Control. 2021 May; 13: e00203. doi: 10.1016/j.parepi.2021.e00203. DOI: https://doi.org/10.1016/j.parepi.2021.e00203
Ahad A, Qadir S, ur Rashid A, Swati AZ. Common hematological abnormalities in patients with malaria presenting at Saidu Teaching Hospital, Swat Pakistan. Pakistan Journal of Medical & Health Sciences. 2022 May; 16(04): 298. doi: 10.53350/pjmhs22164298. DOI: https://doi.org/10.53350/pjmhs22164298
Kotepui M, Kotepui KU, Milanez GD, Masangkay FR. Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: A systematic review, meta-analysis, and analysis of case reports. BMC Infectious Diseases. 2020 Dec; 20(1): 1-4. doi: 10.1186/s12879-020-05046-y. DOI: https://doi.org/10.1186/s12879-020-05046-y
Santos ML, Coimbra RS, Sousa TN, Guimarães LF, Gomes MS, Amaral LR, et al. The interface between inflammatory mediators and MicroRNAs in Plasmodium vivax severe thrombocytopenia. Frontiers in Cellular and Infection Microbiology. 2021 Mar; 11: 631333. doi: 10.3389/fcimb.2021.631333. DOI: https://doi.org/10.3389/fcimb.2021.631333
Alsahli M and Gerich JE. Hypoglycemia in patients with diabetes and renal disease. Journal of Clinical Medicine. 2015 May; 4(5): 948-64. doi: 10.3390/jcm4050948. DOI: https://doi.org/10.3390/jcm4050948
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments